SCHEMBL23930969

SCHEMBL23930969

Cn1cnc(F)c1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.36
GABRA5 P31644 6/20 0.36
GABRG2 P18507 5/20 0.36
GABRB3 P28472 5/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
GABRA3 P34903 4/20 0.35
GABRA6 Q16445 4/20 0.35
GABRA2 P47869 3/20 0.35
GABRA4 P48169 1/20 0.35
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PIK3CD O00329 1/20 0.32
FLT1 P17948 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930918 0.81 GABRA1 (0.36) GABRA1GABRA5GABRG2GABRB3ALDH1A1
SCHEMBL23930860 0.81 APOBEC3A (0.38) ALDH1A1CYP1A2CYP2C9CYP2C19APOBEC3A
SCHEMBL22697032 0.77 MAPK1 (0.43) ALDH1A1APOBEC3AAPOBEC3GMAPTHSD17B10
SCHEMBL21880074 0.74 APOBEC3A (0.41) CYP2C19APOBEC3AAPOBEC3GMAPTKDR
SCHEMBL28811842 0.74 KDR (0.47) GABRA1GABRA5GABRG2GABRB3ALDH1A1
SCHEMBL29779714 0.73 GABRA1 (0.43) GABRA1GABRA5GABRG2GABRB3ALDH1A1
SCHEMBL22696692 0.72 MAPK1 (0.43) GABRA1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL29779719 0.72 PIK3CD (0.35) GABRA1GABRA5GABRG2GABRB3APOBEC3A
SCHEMBL21721397 0.70 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL29779717 0.68 JAK2 (0.48) APOBEC3AAPOBEC3GMAPTPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed